221 related articles for article (PubMed ID: 28975987)
1. Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer.
Wu B; Zhang XJ; Li XG; Jiang LS; He F
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3808-3812. PubMed ID: 28975987
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value.
Yao JT; Zhao SH; Liu QP; Lv MQ; Zhou DX; Liao ZJ; Nan KJ
Pathol Res Pract; 2017 May; 213(5):453-456. PubMed ID: 28343871
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of long non-coding RNA LINC00261 is a prognostic marker for patients with non-small cell lung cancer: a preliminary study.
Liu Y; Xiao N; Xu SF
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5691-5695. PubMed ID: 29272004
[TBL] [Abstract][Full Text] [Related]
6. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
7. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
Tian Y; Feng Y
Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Gong J; Zhang H; He L; Wang L; Wang J
Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
11. BPTF biomarker correlates with poor survival in human NSCLC.
Gong YC; Liu DC; Li XP; Dai SP
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):102-107. PubMed ID: 28121349
[TBL] [Abstract][Full Text] [Related]
12. ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Fan W; Yang H; Xue H; Sun Y; Zhang J
Int J Clin Exp Pathol; 2015; 8(5):5503-8. PubMed ID: 26191257
[TBL] [Abstract][Full Text] [Related]
13. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
15. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and diagnostic significance of long non-coding RNA AGAP2-AS1 levels in patients with non-small cell lung cancer.
Fan KJ; Liu Y; Yang B; Tian XD; Li CR; Wang B
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2392-2396. PubMed ID: 28617550
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
18. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
Wang H; Wang J; Liang CF; Zhou T
Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]